Left Ventricular Mass as a Risk Factor in the Oldest Old

Journal of Clinical Hypertension

Volumn 17, Issue 11, 2015, Pages 874-879

  Bursztyn, Michael ^a   Leibowitz, David ^a   Stessman Lande, Irit ^a   Jacobs, Jeremy M ^a   Ein Mor, Eliana ^a   Stessman, Jochanan ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT;

AGED; ARTICLE; BODY HEIGHT; BODY SURFACE; COHORT ANALYSIS; COMMUNITY SAMPLE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPH; EDUCATIONAL STATUS; FEMALE; FUNCTIONAL DISEASE; HEALTH STATUS; HEART LEFT VENTRICLE MASS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISRAEL; LONGITUDINAL STUDY; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORMAL VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEDENTARY LIFESTYLE; SELF CONCEPT; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VERY ELDERLY; AGE; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART VENTRICLE; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL;

AGE FACTORS; AGED, 80 AND OVER; BODY SURFACE AREA; COHORT STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; ISRAEL; LONGITUDINAL STUDIES; MALE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 84945494748     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12594     Document Type: Article

References (35)

1. He W, Sengupta M, Velkoff VA, DeBarros KA. 65 in the United States: 2005. US Census Bureau. Current Population Reports. 2005:1-230.
2. Kung HC, Hoyert DL, Xu JQ, Murphy SL. Deaths: final data for 2005. Natl Vital Stat Rep. 2008;56:121.
3. Tarazi RC, Foud FM. Reversal of cardiac hypertrophy in humans. Hypertension 1984;6:III140-III146.
4. Fried LP, Kronmal RA, Newman AB, et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA. 1998;279:585-592.
5. Tsang TSM, Barnes ME, Gersh BJ, et al. Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography. J Am Coll Cardiol. 2003;42:1199-1205.
6. Bella JN, Palmieri V, Roman MJ, et al. Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study. Circulation. 2002;105:1928-1933.
7. Zhang Y, Safar ME, Iaria P, et al. Prevalence and prognosis of left ventricular diastolic dysfunction in the elderly: the PROTEGER study. Am Heart J. 2010;160:471-478.
8. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561-1566.
9. Gardin JM, Lauer MS. Left ventricular hypertrophy: the next treatable silent killer? JAMA. 2004;292:2396-2398.
10. Lang RM, Bierig M, Devereaux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79-108.
11. de Simone G, Daniels SR, Devereux RB, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol. 1992;20:1251-1260.
12. Leibowitz D, Stessman-Lande I, Jacobs JM, et al. Cardiac structure and function as predictors of mortality in persons 85 years of age. Am J Cardiol. 2012;109:901-905.
13. Stessman J, Cohen A, Ginsberg GM, et al. The Jerusalem 70-year old longitudinal study. I: description of the initial cross sectional survey. Eur J Epidemiol. 1995;11:675-684.
14. Jacobs JM, Cohen A, Bursztyn M, et al. Cohort profile: the Jerusalem Longitudinal Cohort Study. Int J Epidemiol. 2009;39:1464-1469.
15. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
16. Katz S, Ford AB, Moskowitz RW, et al. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914-919.
17. Gilula Z, Krieger AM. Collapsed two-way contingency tables and the Chi-square reduction principle. J R Stat Soc. 1989;51:425-433.
18. Stessman J, Hammerman-Rozenberg R, Cohen A, et al. Physical activity, function, and longevity among the very old. Arch Intern Med. 2009;169:1476-1483.
19. Leibowitz D, Stessman-Lande I, Jacobs J, et al. Cardiac structure and function in persons 85 years of age. Am J Cardiol. 2011;108:465-470.
20. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-458.
21. Hammond JW, Devereux RB, Alderman MH, et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol. 1986;7:639-650.
22. Levy D, Garrison RJ, Savage DD, et al. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Ann Intern Med. 1989;110:101-107.
23. Aronow WS, Koenigsberg M, Schwartz KS. Usefulness of echocardiographic left ventricular hypertrophy in predicting new coronary events and atheroembolic brain infarction in patients over 62 years of age. Am J Cardiol. 1988;61:1130-1132.
24. Kannel WB. Coronary heart disease risk factors in the elderly. Am J Geriatr Cardiol. 2002;11:101-107.
25. de Ruijter W, Westendorp RG, Assendelft WJ, et al. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ. 2009;338:a3083.
26. Rodondi N, Locatelli I, Aujesky D, et al; Health ABC Study. Framingham risk score and alternatives for prediction of coronary heart disease in older adults. PLoS One. 2012;7:e34287.
27. Psaty BM, Anderson M, Kronmal RA, et al. The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: the Cardiovascular Health Study. J Am Geriatr Soc. 2004;52:1639-1647.
28. Jacobs JM, Stessman J, Ein-Mor E, Bursztyn M. Hypertension and 5-year mortality among 85-year-olds: the Jerusalem Longitudinal Study. J Am Med Dir Assoc. 2012;13:759.e1-759.e6.
29. Stessman J, Jacobs JM, Ein-Mor E, Bursztyn M. Normal body mass index rather then obesity predicts increased mortality in the elderly: the Jerusalem Longitudinal Study. J Am Geriatr Soc. 2009;57:2232-2238.
30. Poortvliet RK, de Ruijter W, de Craen AJ, et al. Blood pressure trends and mortality: the Leiden 85-plus study. J Hypertens. 2013;31:63-70.
31. Aurigemma GP, Silver KH, McLaughlin M, et al. Impact of chamber geometry and gender on left ventricular systolic function in patients > 60 years of age with aortic stenosis. Am J Cardiol. 1994;74:794-798.
32. Garavaglia GE, Messerli FH, Schmieder RE, et al. Sex differences in cardiac adaptation to essential hypertension. Eur Heart J. 1989;10:1110-1114.
33. Peter I, Huggins GS, Shearman AM, et al. Age-related changes in echocardiographic measurements: association with variation in the estrogen receptor-alpha gene. Hypertension. 2007;49:1000-1006.
34. Lieb W, Xanthakis V, Sullivan LM, et al. Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the Framingham Offspring Study. Circulation. 2009;119:3085-3092.
35. Collerton J, Davies K, Jagger C, et al. Health and diseases in 85 year olds: baseline findings from the Newcastle 85+ cohort study. BMJ. 2009;399:b4904.